Abiopharma

🔍 Woelfel Jessica (Executive)

Company: ORMAT TECHNOLOGIES, INC. (ORA)

Report Date: 2026-03-25

Detailed Transactions and Holdings:

• Sold 427 shares of Common Stock at $107.37 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,933.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 834 shares of Common Stock at $110.37 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,099.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 2,666 shares of Common Stock at $110.39 per share (Direct)
  Date: 2026-03-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,433.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Represents shares of common stock sold in the open market on March 25, 2026, pursuant to a 10b5-1 Plan adopted by the reporting person on 06/30/2025, Modified 11/25/2025.
• F2: Represents shares of common stock sold in the open market on March 25, 2026, as part of an automatic sell-to-cover transaction, which was non-discretionary and mandated by the applicable award agreement, in order to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units on March 21, 2026.
• F3: Represents shares of common stock sold in the open market on March 26, 2026, pursuant to a 10b5-1 Plan adopted by the reporting person on 06/30/2025, Modified 11/25/2025.